6 days ago
The monthly report for February shows that there were no new admissions and three cancellations including the departure of long term bear campaign dog Versarien taking the AIM market down to 613 companies. Theis is the lowest level for 23 years and no doubt Crazy Meg at Bloomberg blames that entirely on evil Tom Winnifrith, nobody else. Actually it is even worse than it looks.
161 days ago
In this podcast I look briefly at Skinbiotherapeutics (SBTX) then at Bluebird Mining Ventures (BMV), Kefi Gold & Copper (KEFI), Wishbone (WSBN), BP (BP.) and the oil price and Roquefort Therapeutics (ROQ) which the FCA should be all over like a rash.
200 days ago
In March, the struck off dentist Ajan Rejinald announced that Roquefort Therapeutics (ROQ) was to sell its Oncogeni subsidiary for up to $12 million to Nations Trust Holding LLC. In May we were told the deal would complete in June. It has not and there has been no RNS. I wonder: does Nations Trust Holding LLC actually exist at all?
201 days ago
Roquefort Therapeutics (ROQ) stated in May that the sale of Oncogeni Ltd would see a binding SPA signed in June with completion for up to $12 million “shortly thereafter”. As I flagged up to the FCA yesterday there has been no RNS since June to confirm this or to flag up a problem. So, what does Companies House say?
202 days ago
It would be rude not to write. The FCA should be forcing shitco Roquefort Investments (ROQ) into issuing an RNS. The letter, winged off electronically just now, reads
640 days ago
I have warned before that Roquefort Therapeutics (ROQ) is a Standard listed crock of shite that will end in tears for shareholders. I now ask the question of whether it is already technically insolvent? That matters given the stink around Ashington Innovation (ASHI).
772 days ago
I start with a note on the Hamas lovers at Lancaster University then spend 97% of the podcast on shares: Argentex (AGFX), Ironveld (IRON), Caracal Gold (GCAT), Upland Resources (UPL), EventBrite (US:EB) and in some detail Roquefort Therapeutics (ROQ) which should be a zero.
869 days ago
Patricia Murray of Liverpool has written to the FCA over both Ashington Innovations (ASHI) and Roquefort Therapeutics (ROQ). How a serious regulator can ignore what follows defies belief. Both companies are clearly utterly uninvestable. Ms Murray writes:
1021 days ago
Roquefort (ROQ) was a Standard List shell brought to market by the scumbags at Optiva as s shell in March 2021, raising a Bernie at 5p - I did warn folks about it HERE. Its shares are now suspended at 6.75p as it could not get its accounts out on time. But the history of the main player, CEO Ajan Reginald should be telling you that this is a monumental bargepole and everyone involved, from the FCA downwards should be highly concerned.
